PUT
$0
400
Q2 2024
New holding
CALL
$181,000
4.7K
Q2 2024
Added 5.77%
PUT
$212,000
5.5K
Q2 2024
Added 5.77%
CALL
$808,000
25.7K
Q2 2024
Reduced 33.6%
PUT
$522,000
16.6K
Q2 2024
Reduced 33.6%
CALL
$0
150K
Q2 2024
Added 37.21%
PUT
$0
20.7K
Q2 2024
Added 37.21%
CALL
$2.16 Million
137K
Q2 2024
Reduced 44.5%
PUT
$492,000
31.3K
Q2 2024
Reduced 44.5%
CALL
$2,000
1.9K
Q2 2024
Added 365.0%
PUT
$23,000
18.6K
Q2 2024
Added 365.0%
CALL
$10,000
100
Q2 2024
Reduced 74.55%
PUT
$141,000
1.4K
Q2 2024
Reduced 74.55%
CALL
$990,000
63.4K
Q2 2024
Added 417.7%
PUT
$914,000
58.5K
Q2 2024
Added 417.7%
CALL
$2.11 Million
152K
Q2 2024
Reduced 69.46%
PUT
$323,000
23.3K
Q2 2024
Reduced 69.46%
CALL
$13,000
6.6K
Q2 2024
Reduced 44.0%
PUT
$2,000
1.4K
Q2 2024
Reduced 44.0%
CALL
$0
2.2K
Q2 2024
New holding
PUT
$0
2.2K
Q2 2024
New holding
CALL
$252,000
17.3K
Q2 2024
Reduced 95.82%
PUT
$52,000
3.6K
Q2 2024
Reduced 95.82%
CALL
$63,000
38.1K
Q2 2024
Reduced 33.16%
PUT
$20,000
12.5K
Q2 2024
Reduced 33.16%
Net Lease Office Properties
CALL
$0
50.8K
Q2 2024
Added 269.18%
Net Lease Office Properties
PUT
$0
9.7K
Q2 2024
Added 269.18%
CALL
$0
69.9K
Q2 2024
Added 65.96%
PUT
$0
46.8K
Q2 2024
Added 65.96%
CALL
$7.55 Million
79K
Q2 2024
Added 39.13%
PUT
$13.5 Million
141K
Q2 2024
Added 39.13%
CALL
$406,000
26.6K
Q2 2024
Added 133.73%
PUT
$604,000
39.5K
Q2 2024
Added 133.73%
CALL
$221,000
12.1K
Q2 2024
Added 33.33%
PUT
$7,000
400
Q2 2024
Added 33.33%
PUT
$19,000
7.8K
Q2 2024
Reduced 71.53%
CALL
$80,000
5K
Q2 2024
Added 200.0%
PUT
$101,000
6.3K
Q2 2024
Added 200.0%
Neumora Therapeutics Inc.
CALL
$0
3.1K
Q2 2024
Added 497.92%
Neumora Therapeutics Inc.
PUT
$0
28.7K
Q2 2024
Added 497.92%
CALL
$5 Million
36.3K
Q2 2024
Added 97.89%
PUT
$3.87 Million
28.1K
Q2 2024
Added 97.89%
PUT
$6,000
3.8K
Q2 2024
Added 5.56%
CALL
$63,000
8.4K
Q2 2024
Reduced 96.0%
PUT
$2,000
300
Q2 2024
Reduced 96.0%
CALL
$224,000
26.7K
Q2 2024
Added 141.43%
PUT
$1.02 Million
121K
Q2 2024
Added 141.43%
CALL
$4.85 Million
221K
Q2 2024
Reduced 78.79%
PUT
$5.36 Million
244K
Q2 2024
Reduced 78.79%
PUT
$353,000
125K
Q2 2024
Added 5.58%